7 results
COVID-19 Patient Chest CT - Ground Glass Opacities 

COVID19 Infection - CT Chest, POCUS Echocardiogram and
COVID-19 Patient ... Infection - CT Chest, POCUS ... #SARSCoV2 #CTChest ... #Clinical #CriticalCare ... #GroundGlass #CoronaVirus
COVID-19 POCUS

96 yrs old, discharged 3 wks ago for CAP, treated with amox/clav then cefixime. Returns
COVID-19 POCUS ... Returns for dyspnea ... likely exposure to COVID19 ... #POCUS #Clinical ... Lung #Ultrasound #SARSCoV2
COVID-19 on POCUS

I am infected with COVID-19. This is my own #POCUS 2 days after the
COVID-19 on POCUS ... infected with COVID ... No feeling of dyspnea ... #POCUS #Clinical ... Lung #Ultrasound #SARSCoV2
Dueling analgo-sedative ladders for intubated COVID patients

Dr. Josh Farkas @pulmcirt - Internet Book of Critical Care
for intubated COVID ... Internet Book of Critical ... sedatives #ladders #COVID19 ... #pharmacology # ... management #SARSCOV2
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
COVID-19 - A Seattle ... illness) • 20-40% dyspnea ... unilateral* • POCUS ... Cheatsheet #Diagnosis #Management ... #Summary #SARSCoV2
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
tolerable • Limited clinical ... fever, chills, dyspnea ... Coccidioidomycosis #coccidioides ... #valleyfever #management ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Weaknesses: Limited clinical ... fever, chills, dyspnea ... Coccidioidomycosis #pharmacology ... #management #treatment ... #coccidioides